NITROGLYCERIN

1. PURPOSE

To authorize CCP’s to initiate, monitor and adjust existing Nitroglycerin infusions

2. POLICY

2.1. CCP’s are permitted to monitor and adjust Nitroglycerin infusions during interfacility transports.
2.2. CCP’s may initiate Nitroglycerin infusions with a physician consult.

3. PROCEDURE

3.1. Regulation of the infusion rate will occur within parameters as defined by the transferring or base
hospital physician, but in no case will changes be greater than 10 mcg/min increments q 5 mins.
3.2. In cases of severe hypotension, the medication infusion will be discontinued, and the transferring

or base hospital physician notified.

3.3. Severe hypotension (MAP<65 mmHg) that does not improve following discontinuation of the
infusion should be treated with a 500-1,000 ml fluid bolus as appropriate based on patient
condition.

4. ADMINISTRATION

4.1. Initiate infusion at 10 mcg/min and increase dose by 5-10 mcg/min q 5 mins until marked

decrease or elimination of pain while maintaining MAP > 65mmHg.

4.2. To mix the infusion add 50 mg Nitroglycerin in 250 ml D5W or NS to equal concentration of 200

mcg/ml.

21

